secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001104659-23-023518
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio launches two larger OviTex LPR configurations for large abdominal hernia repair
--------------------------------------------------------------------------------

- New 15x20 cm and 15x25 cm ellipse sizes for ventral and incisional hernias.
- Designed for robotic and laparoscopic ports; low profile facilitates minimally invasive placement.
- In prior quarter, 40% of OviTex cases were robotic and 20% laparoscopic.
- OviTex LPR initially commercialized in 2018; new sizes expand product portfolio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465923023518/0001104659-23-023518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465923023518/tm237356d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-023518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer